Patents by Inventor Kristin W. Livezey

Kristin W. Livezey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11198913
    Abstract: Provided are compositions, kits, and methods for the identification of Listeria. In certain aspects and embodiments, the compositions, kits, and methods may provide improvements in relation to specificity, sensitivity, and speed of detection.
    Type: Grant
    Filed: October 25, 2019
    Date of Patent: December 14, 2021
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Michael R. Reshatoff, Kristin W. Livezey, James J. Hogan
  • Publication number: 20210024982
    Abstract: The present invention provides compositions, kits and methods for the selective hybridization and capture of a specific target nucleic acid. The specific target nucleic acid may be present in a heterogeneous mixture of nucleic acids. Selective hybridization and capture provides a target nucleic acid that is substantially free of non-target and/or contaminating nucleic acids. Target nucleic acids that have been selectively hybridized and captured using the current invention are then used in subsequent analysis, wherein the presence of non-target and/or contaminating nucleic acids that interfere with said subsequent analysis have been substantially reduced or eliminated, thereby providing improved analysis results.
    Type: Application
    Filed: October 1, 2020
    Publication date: January 28, 2021
    Applicant: GEN-PROBE INCORPORATED
    Inventors: Michael M. BECKER, Kristin W. LIVEZEY, Wai-Chung LAM
  • Patent number: 10829801
    Abstract: The present invention provides compositions, kits and methods for the selective hybridization and capture of a specific target nucleic acid. The specific target nucleic acid may be present in a heterogeneous mixture of nucleic acids. Selective hybridization and capture provides a target nucleic acid that is substantially free of non-target and/or contaminating nucleic acids. Target nucleic acids that have been selectively hybridized and captured using the current invention are then used in subsequent analysis, wherein the presence of non-target and/or contaminating nucleic acids that interfere with said subsequent analysis have been substantially reduced or eliminated, thereby providing improved analysis results.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: November 10, 2020
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Michael M. Becker, Kristin W. Livezey, Wai-Chung Lam
  • Patent number: 10689712
    Abstract: Compositions, reaction mixtures, kits and methods used in amplifying and detecting nucleic acids from various species of the class Mollicutes. Particular regions of the 23S rRNA or its gene have been identified as preferred targets for nucleic acid amplification reactions of a sample suspected containing at least one species of Mollicutes. Some oligomers comprise tag regions, target closing regions, promoter sequences, and/or binding moieties. Samples can be from any source suspected of containing a species of the class Mollicutes. Preferred sample sources include bioreactors, cell lines, cell culture wares and pharmaceutical manufacturing wares.
    Type: Grant
    Filed: September 8, 2017
    Date of Patent: June 23, 2020
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Shannon K. Kaplan, Kristin W. Livezey, Michael M. Becker, James J. Hogan
  • Publication number: 20200048684
    Abstract: Provided are compositions, kits, and methods for the identification of Listeria. In certain aspects and embodiments, the compositions, kits, and methods may provide improvements in relation to specificity, sensitivity, and speed of detection.
    Type: Application
    Filed: October 25, 2019
    Publication date: February 13, 2020
    Inventors: Michael R. Reshatoff, Kristin W. Livezey, James J. Hogan
  • Patent number: 10501812
    Abstract: Provided are compositions, kits, and methods for the identification of Listeria. In certain aspects and embodiments, the compositions, kits, and methods may provide improvements in relation to specificity, sensitivity, and speed of detection.
    Type: Grant
    Filed: February 3, 2017
    Date of Patent: December 10, 2019
    Assignee: Gen-Probe Incorporated
    Inventors: Michael R. Reshatoff, Kristin W. Livezey, James J. Hogan
  • Patent number: 10316352
    Abstract: The present invention provides compositions, kits and methods for the selective hybridization and capture of a specific target nucleic acid. The specific target nucleic acid may be present in a heterogeneous mixture of nucleic acids. Selective hybridization and capture provides a target nucleic acid that is substantially free of non-target and/or contaminating nucleic acids. Target nucleic acids that have been selectively hybridized and captured using the current invention are then used in subsequent analysis, wherein the presence of non-target and/or contaminating nucleic acids that interfere with said subsequent analysis have been substantially reduced or eliminated, thereby providing improved analysis results.
    Type: Grant
    Filed: May 13, 2009
    Date of Patent: June 11, 2019
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Michael M. Becker, Kristin W. Livezey, Wai-Chung Lam
  • Publication number: 20190024158
    Abstract: The present invention provides nucleic acid amplification systems and methods that desirably reduce or eliminate false positive amplification signals resulting from contaminating biological material, e.g., nucleic acid, that may be present in one or more reagents used in an amplification reaction and/or that may be present in the environment in which an amplification reaction is performed. The invention offers the further advantage of requiring less stringent purification and/or sterility efforts than conventionally needed in order to ensure that enzymes and other reagents used in amplification reactions, and the environment in which an amplification reaction is performed, are free of bacterial or other nucleic acid contamination that may yield false positive results.
    Type: Application
    Filed: March 14, 2016
    Publication date: January 24, 2019
    Inventors: Michael M. BECKER, Kristin W. LIVEZEY, Wai-Chung LAM
  • Patent number: 10167500
    Abstract: The present invention provides nucleic acid amplification systems and methods that desirably reduce or eliminate false positive amplification signals resulting from contaminating biological material, e.g., nucleic acid, that may be present in one or more reagents used in an amplification reaction and/or that may be present in the environment in which an amplification reaction is performed. The invention offers the further advantage of requiring less stringent purification and/or sterility efforts than conventionally needed in order to ensure that enzymes and other reagents used in amplification reactions, and the environment in which an amplification reaction is performed, are free of bacterial or other nucleic acid contamination that may yield false positive results.
    Type: Grant
    Filed: March 14, 2016
    Date of Patent: January 1, 2019
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Michael M. Becker, Kristin W. Livezey, Wai-Chung Lam
  • Patent number: 9920382
    Abstract: Compositions, reaction mixtures, kits and methods used in amplifying and detecting nucleic acids from various species of the class Mollicutes. Particular regions of the 23S rRNA or its gene have been identified as preferred targets for nucleic acid amplification reactions of a sample suspected containing at least one species of Mollicutes. Some oligomers comprise tag regions, target closing regions, promoter sequences, and/or binding moieties. Samples can be from any source suspected of containing a species of the class Mollicutes. Preferred sample sources include bioreactors, cell lines, cell culture wares and pharmaceutical manufacturing wares.
    Type: Grant
    Filed: November 11, 2015
    Date of Patent: March 20, 2018
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Shannon K. Kaplan, Kristin W. Livezey, Michael M. Becker, James J. Hogan
  • Publication number: 20180073059
    Abstract: Compositions, reaction mixtures, kits and methods used in amplifying and detecting nucleic acids from various species of the class Mollicutes. Particular regions of the 23S rRNA or its gene have been identified as preferred targets for nucleic acid amplification reactions of a sample suspected containing at least one species of Mollicutes. Some oligomers comprise tag regions, target closing regions, promoter sequences, and/or binding moieties. Samples can be from any source suspected of containing a species of the class Mollicutes. Preferred sample sources include bioreactors, cell lines, cell culture wares and pharmaceutical manufacturing wares.
    Type: Application
    Filed: September 8, 2017
    Publication date: March 15, 2018
    Inventors: Shannon K. KAPLAN, Kristin W. LIVEZEY, Michael M. BECKER, James J. HOGAN
  • Publication number: 20180010172
    Abstract: The present invention provides compositions, kits and methods for the selective hybridization and capture of a specific target nucleic acid. The specific target nucleic acid may be present in a heterogeneous mixture of nucleic acids. Selective hybridization and capture provides a target nucleic acid that is substantially free of non-target and/or contaminating nucleic acids. Target nucleic acids that have been selectively hybridized and captured using the current invention are then used in subsequent analysis, wherein the presence of non-target and/or contaminating nucleic acids that interfere with said subsequent analysis have been substantially reduced or eliminated, thereby providing improved analysis results.
    Type: Application
    Filed: September 18, 2017
    Publication date: January 11, 2018
    Inventors: Michael M. BECKER, Kristin W. LIVEZEY, Wai-Chung LAN
  • Patent number: 9765403
    Abstract: Compositions, reaction mixtures, kits and methods used in amplifying and detecting nucleic acids from various species of the class Mollicutes. Particular regions of the 23S rRNA or its gene have been identified as preferred targets for nucleic acid amplification reactions of a sample suspected containing at least one species of Mollicutes. Some oligomers comprise tag regions, target closing regions, promoter sequences, and/or binding moieties. Samples can be from any source suspected of containing a species of the class Mollicutes. Preferred sample sources include bioreactors, cell lines, cell culture wares and pharmaceutical manufacturing wares.
    Type: Grant
    Filed: November 11, 2015
    Date of Patent: September 19, 2017
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Shannon K. Kaplan, Kristin W. Livezey, Michael M. Becker, James J. Hogan
  • Publication number: 20170211132
    Abstract: Provided are compositions, kits, and methods for the identification of Listeria. In certain aspects and embodiments, the compositions, kits, and methods may provide improvements in relation to specificity, sensitivity, and speed of detection.
    Type: Application
    Filed: February 3, 2017
    Publication date: July 27, 2017
    Inventors: Michael R. RESHATOFF, Kristin W. LIVEZEY, James J. HOGAN
  • Patent number: 9593383
    Abstract: Provided are compositions, kits, and methods for the identification of Listeria. In certain aspects and embodiments, the compositions, kits, and methods may provide improvements in relation to specificity, sensitivity, and speed of detection.
    Type: Grant
    Filed: May 2, 2014
    Date of Patent: March 14, 2017
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Michael R. Reshatoff, Kristin W. Livezey, James J. Hogan
  • Publication number: 20160186249
    Abstract: The present invention provides nucleic acid amplification systems and methods that desirably reduce or eliminate false positive amplification signals resulting from contaminating biological material, e.g., nucleic acid, that may be present in one or more reagents used in an amplification reaction and/or that may be present in the environment in which an amplification reaction is performed. The invention offers the further advantage of requiring less stringent purification and/or sterility efforts than conventionally needed in order to ensure that enzymes and other reagents used in amplification reactions, and the environment in which an amplification reaction is performed, are free of bacterial or other nucleic acid contamination that may yield false positive results.
    Type: Application
    Filed: March 14, 2016
    Publication date: June 30, 2016
    Inventors: Michael M. BECKER, Kristin W. LIVEZEY, Wai-Chung LAM
  • Patent number: 9284549
    Abstract: The present invention provides nucleic acid amplification systems and methods that desirably reduce or eliminate false positive amplification signals resulting from contaminating biological material, e.g., nucleic acid, that may be present in one or more reagents used in an amplification reaction and/or that may be present in the environment in which an amplification reaction is performed. The invention offers the further advantage of requiring less stringent purification and/or sterility efforts than conventionally needed in order to ensure that enzymes and other reagents used in amplification reactions, and the environment in which an amplification reaction is performed, are free of bacterial or other nucleic acid contamination that may yield false positive results.
    Type: Grant
    Filed: October 10, 2013
    Date of Patent: March 15, 2016
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Michael M. Becker, Kristin W. Livezey, Wai-Chung Lam
  • Publication number: 20160060685
    Abstract: Compositions, reaction mixtures, kits and methods used in amplifying and detecting nucleic acids from various species of the class Mollicutes. Particular regions of the 23S rRNA or its gene have been identified as preferred targets for nucleic acid amplification reactions of a sample suspected containing at least one species of Mollicutes. Some oligomers comprise tag regions, target closing regions, promoter sequences, and/or binding moieties. Samples can be from any source suspected of containing a species of the class Mollicutes. Preferred sample sources include bioreactors, cell lines, cell culture wares and pharmaceutical manufacturing wares.
    Type: Application
    Filed: November 11, 2015
    Publication date: March 3, 2016
    Inventors: Shannon K. KAPLAN, Kristin W. LIVEZEY, Michael M. BECKER, James J. HOGAN
  • Patent number: 9212397
    Abstract: Compositions, reaction mixtures, kits and methods used in amplifying and detecting nucleic acids from various species of the class Mollicutes. Particular regions of the 23S rRNA or its gene have been identified as preferred targets for nucleic acid amplification reactions of a sample suspected containing at least one species of Mollicutes. Some oligomers comprise tag regions, target closing regions, promoter sequences, and/or binding moieties. Samples can be from any source suspected of containing a species of the class Mollicutes. Preferred sample sources include bioreactors, cell lines, cell culture wares and pharmaceutical manufacturing wares.
    Type: Grant
    Filed: June 23, 2010
    Date of Patent: December 15, 2015
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Shannon K. Kaplan, Kristin W. Livezey, Michael M. Becker, James J. Hogan
  • Patent number: RE48909
    Abstract: The present invention provides nucleic acid amplification systems and methods that desirably reduce or eliminate false positive amplification signals resulting from contaminating biological material, e.g., nucleic acid, that may be present in one or more reagents used in an amplification reaction and/or that may be present in the environment in which an amplification reaction is performed. The invention offers the further advantage of requiring less stringent purification and/or sterility efforts than conventionally needed in order to ensure that enzymes and other reagents used in amplification reactions, and the environment in which an amplification reaction is performed, are free of bacterial or other nucleic acid contamination that may yield false positive results.
    Type: Grant
    Filed: April 29, 2019
    Date of Patent: February 1, 2022
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Michael M. Becker, Kristin W. Livezey, Wai-Chung Lam